natu-nov-15-07-p002_SPOT 8/11/07 9:31 Page 14
Cell Therapy and Immunology
at Fraunhofer IZI
The Fraunhofer Gesellschaft (FhG) is Europe´s largest organi- deavours to offer contract research for private and public customers.
zation for applied research with more than 12.500 employees and However, it encourages within its core competencies investigator-driven
an excellent reputation for highly innovative developments in its 56 research projects � nanced by internal resources. Fraunhofer IZI is con-
TLIGHT ON GERMANY
well equipped institutes. cerned with research and development in cell technologies and immu-
SPO
nology which contribute in the broadest sense to the diagnosis of organ
ABOUT THE INSTITUTE function and the subsequent reestablishment of their functions. For this
The Fraunhofer Institute for Cell Therapy and Immunology (IZI) is purpose the institute supports the development, the production, clinical
one of the youngest institutes of the FhG Life Sciences branch and was examination and regulatory authorization of diagnostic and therapeutic
established in 2005 in Leipzig in the state of Saxony. Leipzig, a univer- procedures and products, which serve this goal.
sity town with more than 30.000 students is located in the heart of East
Germany and is only one hour by train from Berlin. The Universtity RESEARCH AND DEVELOPMENT PROFILE
and modern hospital infrastructure represent a center of biotechnology Research and product prototypes which can be developed with the
research in the former East Germany. Last year, through a joint action Fraunhofer IZI include:
of the Federal and the Saxonian gov- – Pharmaceutically relevant ligands (e. g. monoclonal antibodies)
ernment Leipzig received nearly 40 – Vaccines and cellular immune regulators
million � to establish a Translation
Berlin
– Tissue and organ regeneration factors
Center for Regenerative Medicine.
Leipzig
– Cell lines and tissue preparations
This center and the university hos- – Technical sensor and assistance systems
pital and medical center are com- – Functional and molecular imaging
plementary and scienti � cally closely – Small and large animal disease models (e. g. stro Ne, arthritis)
lin Ned to IZI. Fraunhofer IZI is developing novel technology in-house; as the only
German partner in the international ENCODE consortium IZI is investi-
ABOUT RESEARCH AT IZI gating the potential of non-coding ncRNA which are poised to become
The mission of the Fraunhofer IZI is to translate bench science into effective new diagnostic and therapeutic tools.
prototypes, diagnostics and therapies. IZI excels in an interactive and In addition, both the organization and consultation in regards to clini-
interdisciplinary scienti � c environment and modern technologies. It en- cal trials in phases I to II as well as associated support is included with
submission of cell and pharma-product applications or with the acquisi-
tion of manufacturing authorization.
CORE COMPETENCIES OF IZI
– Cell Biology
– Bio-Technologies
The expansion of the current institute into a new, ultramodern build- – Therapies and Disease Models
ing offers the possibility for enhancing signi � cantly the personnel frame – Immunology and Vaccine Development
of the institute. – Molecular Biology and Personalized Medicine
– Functional Molecular Imaging
WE SEEK AMBITIOUS SCIENTISTS … – Quality Assurance (GLP, GMP, GCP)
… who are interested in joining existing groups or in establishing new Research MANUFACTURING Application
groups which will contribute to and shape the future of the Fraunhofer
CONCEPTS
IZI. Ta Ne this opportunity to ta Ne advantage of the synergies of the vari-
ous groups within and associated with the IZI to develop your own ideas
GLP Qualtity GMP Quality GCP Quality
into fascinating research projects.
As an employer, the Fraunhofer Gesellschaft offers a platform that
enables its staff to develop the professional and personal s Nills that will CONTACT
allow them to ta Ne up positions of responsibility within their institutes, Fraunhofer Institute for
in other scienti � c domains, in industry and in society. The FhG pays Cell Therapy and Immunology
salaries according to TVöD (federal) supplemented by an outcome- Deutscher Platz 5e
7
related bene � t system. D-04103 Leipzig
If you are considering joining IZI, please send your application with Phone +49 (0) 341 / 355 36-0
a statement regarding research and career interests, CV, list of publica- Fax +49 (0) 341 / 355 36-109
tions, patents and project acquisition records, two letters of reference,
info@izi.fraunhofer.de
v
ember 200
copies of relevant certi � cates (e. g. academic merits, prizes, stipends).
WWW.IZI.FRAUNHOFER.DE
|
15 No
For further information please contact:
JOBS Head of Institute
Prof. Dr. Fran N Emmrich
TURE
Phone +49 (0) 341 / 97 25 500
W116116R
|
NA
14
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58